Page last updated: 2024-08-21

pyrazines and Stomatitis, Vesicular

pyrazines has been researched along with Stomatitis, Vesicular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Nace, RA; Russell, SJ; Yarde, DN	1

Other Studies

1 other study(ies) available for pyrazines and Stomatitis, Vesicular

Article	Year
Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo. Experimental hematology, 2013, Volume: 41, Issue:12 Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cells, Cultured; Combined Modality Therapy; Cricetinae; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Mice; Multiple Myeloma; NF-kappa B; Oncolytic Virotherapy; Pyrazines; Real-Time Polymerase Chain Reaction; Vesicular Stomatitis; Vesicular stomatitis Indiana virus; Virus Replication	2013

Article

Year

Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo.

Experimental hematology, 2013, Volume: 41, Issue:12

Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cells, Cultured; Combined Modality Therapy; Cricetinae; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Mice; Multiple Myeloma; NF-kappa B; Oncolytic Virotherapy; Pyrazines; Real-Time Polymerase Chain Reaction; Vesicular Stomatitis; Vesicular stomatitis Indiana virus; Virus Replication

2013